ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 67 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $103,000 | -13.4% | 254,200 | 0.0% | 0.00% | – |
| Q1 2016 | $119,000 | -31.2% | 254,200 | 0.0% | 0.00% | – |
| Q4 2015 | $173,000 | -30.0% | 254,200 | 0.0% | 0.00% | – |
| Q3 2015 | $247,000 | -19.0% | 254,200 | 0.0% | 0.00% | – |
| Q2 2015 | $305,000 | -35.1% | 254,200 | -46.2% | 0.00% | -100.0% |
| Q1 2015 | $470,000 | 0.0% | 472,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $470,000 | +21.1% | 472,400 | +31.6% | 0.00% | 0.0% |
| Q3 2014 | $388,000 | -7.2% | 359,000 | -10.6% | 0.00% | 0.0% |
| Q2 2014 | $418,000 | +16.4% | 401,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $359,000 | +372.4% | 401,700 | +520.9% | 0.00% | – |
| Q4 2013 | $76,000 | -32.1% | 64,700 | -2.7% | 0.00% | – |
| Q3 2013 | $112,000 | +10.9% | 66,490 | +31.2% | 0.00% | – |
| Q2 2013 | $101,000 | – | 50,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|